Go Pro
OTCMKTS:CBDL

CBD Life Sciences (CBDL) Stock Price, News & Analysis

CBD Life Sciences logo
$0.0002 0.00 (0.00%)
As of 10:09 AM Eastern

About CBD Life Sciences Stock (OTCMKTS:CBDL)

Advanced

Key Stats

Today's Range
$0.0001
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
$0.0010
Volume
238,526 shs
Average Volume
15.77 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CBD Life Sciences, Inc. is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support. Many of these products incorporate proprietary formulations and delivery systems intended to enhance bioavailability and absorption. CBD Life Sciences emphasizes rigorous quality control, sourcing non-GMO, pesticide-free hemp and subjecting finished goods to third‐party laboratory testing for potency, purity and compliance with federal guidelines.

CBD Life Sciences markets its products through multiple channels, including direct-to-consumer e-commerce platforms, retail partnerships and select distribution agreements across North America. The company has pursued strategic alliances with contract manufacturers and fulfillment providers to scale production capacity and streamline logistics. While still in its early commercial stages, CBD Life Sciences is positioning itself to capitalize on growing consumer interest in plant-based wellness solutions.

Leadership at CBD Life Sciences comprises professionals with backgrounds in nutraceutical development, pharmaceutical manufacturing and consumer packaged goods. This management team oversees research and development efforts, regulatory compliance initiatives and brand-building activities. As regulatory frameworks for hemp-derived cannabinoids continue to evolve, the company remains focused on innovation, quality assurance and expanding its retail footprint.

AI Generated. May Contain Errors.

Receive CBDL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CBD Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBDL Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
See More Headlines

CBDL Stock Analysis - Frequently Asked Questions

CBD Life Sciences' stock was trading at $0.0002 on January 1st, 2026. Since then, CBDL shares have increased by 0.0% and is now trading at $0.0002.

Shares of CBDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CBD Life Sciences investors own include 3D Systems (DDD), Baidu (BIDU), Silver Bull Resources (SVBL), Workday (WDAY), Zoom Communications (ZM), Clean Energy Fuels (CLNE) and ContextLogic (WISH).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:CBDL
CIK
1776073
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:CBDL) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners